Bharat Rasayan enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
1,569————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
27227228612548.6
1.21.285.280.527.9
1,297————
−271−271−200−44.2−20.7
₹780.58————
1,2761,2761,2151,068921
0.1%0.1%7.0%7.5%3.0%
0.00×————
1.08×————
7.34×————
8.67×————
22.17×————
Reference items — trailing FY values
1,2031,2421,1731,0451,234
177199175117197
15017314891.5171
—13217241.1213
58.558.513614.0190
—57.413513.3188
—73.535.727.123.5
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHARATRAS₹943.70

Bharat Rasayan Limited

· Chemicals
₹ CrorePeersINSECTICIDIPLMOLGSPCROPPUNJABCHEMASTECBHAGCHEMNACLINDMcap ₹1,569 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization————1,568.5
- Cash, Equiv & ST Investments48.6124.6285.5272.3272.3
+ Total Debt27.980.585.21.21.2
Enterprise Value————1,297.4
Net Debt (memo)-20.7-44.2-200.3-271.1-271.1
EV per Share————780.58
Total Capital921.21,068.41,215.21,276.01,276.0
Total Debt/Total Capital3.037.537.010.100.10
Total Debt/EV————0.00
EV/Sales————1.08
EV/EBITDA————7.34
EV/EBIT————8.67
EV/Free Cash Flow————22.17
Reference Items — Trailing FY Values
Sales1,234.31,044.61,173.01,241.81,202.6
EBITDA197.3117.3174.9199.1176.7
EBIT171.391.5147.9172.8149.7
Operating Cash Flow213.341.1172.0132.0—
Free Cash Flow189.814.0136.358.558.5
FCFF (free cash flow to the firm)188.213.3135.157.4—
Capital Expenditure23.527.135.773.5—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.